Active Lysosomal Nanoplatform for Ferroptosis-Enhanced Immunotherapy via Tumor Extracellular Matrix Remodeling
ACS Nano · 2026
DOI: 10.1021/acsnano.5c22516 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Jieya Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The First Affiliated Hospital of Soochow University, State Key Laboratory of Radiation Medicine and Protection, School for R…. Hauptthemen laut MEDLINE: Ferroptosis, Lysosomes, Immunotherapy, Extracellular Matrix. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, Priority Academic Program Development of Jiangsu Higher Education Institutions, Jiangsu Funding Program for Excellent Postdoctoral Talent.
Abstract (Originalsprache)
The therapeutic efficacy of nanomedicines in solid tumors is often limited by rapid systemic clearance, dense extracellular matrix (ECM) barriers, poor tumor cell selectivity, and an immunosuppressive tumor microenvironment. Herein, we report an active lysosome-encapsulated hollow mesoporous Prussian blue nanoparticle platform that sequentially overcomes these challenges through prolonged circulation, ECM remodeling, tumor-targeted delivery, and immune modulation of the tumor microenvironment in a subcutaneous 4T1 tumor model. The lysosomal membrane enhances biocompatibility and circulation time, facilitating preferential tumor accumulation. Upon arrival, retained lysosomal hydrolases, including cathepsins B, K, L, and S, degrade ECM components, enabling deep nanoparticle penetration and immune cell infiltration. In the tumor parenchyma, lysosomal membrane encapsulation enhances cellular uptake, leading to iron overload and lipid peroxidation-driven ferroptosis, further amplified by nuclear receptor coactivator 4 (NCOA4)-mediated ferritinophagy. Proteomic profiling revealed increased oxidative stress and local remodeling of the tumor immune microenvironment, corroborated by dendritic cell maturation, CD8+ T cell infiltration, and macrophage polarization. These effects collectively remodeled the immunosuppressive tumor niche. Compared with conventional biological membrane coatings such as red blood cell-derived vesicles, this lysosome-based system exhibits enhanced tumor accumulation, enzymatic functionality, and immunotherapeutic synergy. These findings highlight lysosome-encapsulated nanomedicine as a potential platform for ECM remodeling-facilitated immunotherapy with broad potential across therapeutic modalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, The First Affiliated Hospital of Soochow University, State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Inno…
- School of Life Sciences, Soochow University, Suzhou215123, China.
- Biomedical Basic Research Center (BBRC) of Jiangsu Province, Soochow University, Suzhou215123, China.
ORCID-Profile: Mengdan Xu, Jianxian Ge, Jianfeng Zeng, Mingyuan Gao
Förderung
- Natural Science Foundation of Jiangsu Province
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Jiangsu Funding Program for Excellent Postdoctoral Talent
- National Natural Science Foundation of China (NSFC)
- Suzhou Fundamental Research Project
Zitieren
APA
Chen, J., Cao, X., Zhang, Q., Xiao, X., Xu, M., Wu, M., Shi, Y., Xu, K., Hu, X., Qi, H., Wang, N., Ge, J., Zeng, J., & Gao, M. (2026). Active Lysosomal Nanoplatform for Ferroptosis-Enhanced Immunotherapy via Tumor Extracellular Matrix Remodeling. ACS Nano. https://doi.org/10.1021/acsnano.5c22516
Vancouver
Chen J, Cao X, Zhang Q, Xiao X, Xu M, Wu M, et al. Active Lysosomal Nanoplatform for Ferroptosis-Enhanced Immunotherapy via Tumor Extracellular Matrix Remodeling. ACS Nano. 2026. doi:10.1021/acsnano.5c22516
BibTeX
@article{Chen2026,
author = {Chen, Jieya and Cao, Xiaoyi and Zhang, Qianqian and Xiao, Xiao and Xu, Mengdan and Wu, Mengyao and Shi, Yadan and Xu, Keyang and Hu, Xiuqi and Qi, Haodi and Wang, Ning and Ge, Jianxian and Zeng, Jianfeng and Gao, Mingyuan},
title = {Active Lysosomal Nanoplatform for Ferroptosis-Enhanced Immunotherapy via Tumor Extracellular Matrix Remodeling},
journal = {ACS Nano},
year = {2026},
doi = {10.1021/acsnano.5c22516}
}
EUVIMED